Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Cash Flow-to-Debt Ratio
Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥69.15 Million could theoretically repay 0% of its total liabilities (CN¥2.84 Billion) in one year. See Anhui Fengyuan Pharmaceutical Co Ltd (000153) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Anhui Fengyuan Pharmaceutical Co Ltd across 27 annual periods. Also explore 000153 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Year-by-year debt coverage analysis for Anhui Fengyuan Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Anhui Fengyuan Pharmaceutical Co Ltd (000153) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥119.30 Million | CN¥2.93 Billion | ▼ -14.5% |
| 2024 | 0.05x | CN¥126.24 Million | CN¥2.65 Billion | ▼ -53.8% |
| 2023 | 0.10x | CN¥254.75 Million | CN¥2.47 Billion | ▼ -36.4% |
| 2022 | 0.16x | CN¥439.99 Million | CN¥2.71 Billion | ▲ +53.9% |
| 2021 | 0.11x | CN¥237.88 Million | CN¥2.26 Billion | ▼ -21.3% |
| 2020 | 0.13x | CN¥292.75 Million | CN¥2.19 Billion | ▲ +351.1% |
| 2019 | 0.03x | CN¥66.21 Million | CN¥2.23 Billion | ▼ -78.2% |
| 2018 | 0.14x | CN¥233.59 Million | CN¥1.72 Billion | ▲ +301.9% |
| 2017 | 0.03x | CN¥52.40 Million | CN¥1.55 Billion | ▼ -42.1% |
| 2016 | 0.06x | CN¥78.21 Million | CN¥1.34 Billion | ▲ +44.1% |
| 2015 | 0.04x | CN¥45.50 Million | CN¥1.12 Billion | ▲ +321.1% |
| 2014 | 0.01x | CN¥10.51 Million | CN¥1.09 Billion | ▲ +112.7% |
| 2013 | -0.08x | CN¥-70.31 Million | CN¥926.72 Million | ▼ -212.3% |
| 2012 | 0.07x | CN¥45.65 Million | CN¥675.47 Million | ▼ -32.1% |
| 2011 | 0.10x | CN¥55.06 Million | CN¥552.99 Million | ▼ -5.6% |
| 2010 | 0.11x | CN¥55.04 Million | CN¥522.02 Million | ▲ +71.4% |
| 2009 | 0.06x | CN¥32.41 Million | CN¥526.78 Million | ▼ -36.8% |
| 2008 | 0.10x | CN¥49.82 Million | CN¥511.47 Million | ▼ -20.7% |
| 2007 | 0.12x | CN¥55.26 Million | CN¥449.73 Million | ▲ +50.8% |
| 2006 | 0.08x | CN¥36.27 Million | CN¥445.10 Million | ▲ +15.2% |
| 2005 | 0.07x | CN¥34.88 Million | CN¥493.08 Million | ▲ +284.0% |
| 2004 | -0.04x | CN¥-11.72 Million | CN¥304.86 Million | ▲ +46.0% |
| 2003 | -0.07x | CN¥-11.46 Million | CN¥160.93 Million | ▼ -184.0% |
| 2002 | 0.08x | CN¥10.48 Million | CN¥123.55 Million | ▼ -37.6% |
| 2001 | 0.14x | CN¥23.57 Million | CN¥173.33 Million | ▼ -46.3% |
| 2000 | 0.25x | CN¥25.88 Million | CN¥102.28 Million | ▲ +1939.0% |
| 1999 | 0.01x | CN¥1.01 Million | CN¥81.65 Million | — |